LHC Group to present at Cowen 42nd Annual Healthcare Conference
Get Alerts LHCG Hot Sheet
Join SI Premium – FREE
LAFAYETTE, La., March 3, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the Cowen 42nd Annual Healthcare Conference on Tuesday, March 8 at 2:50 p.m. Eastern time.
To access a live webcast, listeners should go to the Investor Relations section of the Company's website, www.LHCgroup.com, approximately 15 minutes prior to the event to register and download any necessary software. For those unable to listen to the live broadcasts, replays will be available for 30 days on the Company's website.
About LHC Group, Inc.LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the nation, offering quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. The company's 30,000 employees deliver home health, hospice, home- and community-based services, and facility-based care in 37 states and the District of Columbia – reaching 60 percent of the U.S. population aged 65 and older. Through Imperium Health, the company's ACO management and enablement company, LHC Group helps partners improve both savings and patient outcomes with a value-based approach. As the preferred joint venture partner for more than 400 leading U.S. hospitals and health systems, LHC Group works in cooperation with providers to customize each partnership and reach more patients and families with an effective and efficient model of care.
Contact: | Eric Elliott |
Senior Vice President of Finance | |
(337) 233-1307 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/lhc-group-to-present-at-cowen-42nd-annual-healthcare-conference-301494356.html
SOURCE LHC Group, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Signia Introduces MaX, Powered by Acoustic Intelligence™: World's First AI Hearing Aid Platform with 4 DNNs
- GC Biopharma's Hunter Syndrome Treatment 'Hunterase' Receives Drug Approval in India and Taiwan
- Fasset Hits $1B Valuation as SBI Group Leads $68M Series C to Scale AI-Powered Stablecoin Neobanking
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share